跳至主要内容
临床试验/NCT05055830
NCT05055830招募中不适用

Clinically Integrated Opportunistic PK/PD Trial in Critically Ill Children

Duke University1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2021年10月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
1
主要终点
Clearance (CL) or apparent oral clearance (CL/F) as measured by PK sampling

研究概览

简要总结

OPTIC is a prospective, open-label, non-randomized study of multiple medications administered to approximately 2000 children in the pediatric cardiac intensive care unit (PCICU) per routine clinical car by their treating provider. The purpose of this study is to characterize the PK of drugs routinely administered to children per standard of care using opportunistic and scavenged samples. The prescribing of drugs to children will not be part of this protocol.

After the child/adult (<21 years of age) is consented/enrolled, demographic and clinical data will be extracted from the EHR. Biospecimen information (including date and time of sample collection) will be collected.

Data analysis will be conducted on all participants with at least 2 evaluable samples. The protocol represents minimal risk to the children/adults who provide body fluid for this study, including potential loss of confidentiality (samples will be assigned a unique accession number) and risks associated with blood draws. Adverse Events (AEs)/Serious Adverse Events (SAEs) caused by the study specimen collections will be monitored and recorded in the Electronic Data Capture (EDC) system.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
0 Months 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • To be eligible for enrollment, a potential participant must meet all the following criteria:
  • Participant is <21 years old on admission
  • Participant is admitted to the Pediatric Cardiac Intensive Care Unit
  • Parent/legal guardian/adult participant can understand the consent process and is willing to provide informed consent/assent
  • Participant is receiving one or more of the study drugs of interest at the time of enrollment

排除标准

  • 1. Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study

研究组 & 干预措施

Children (<21 years of age) who are prescribed drugs of interest

Children and young adults who are prescribed drugs of interest as part of their routine medical care and are admitted to the pediatric cardiac intensive care unit

干预措施: The OPTIC study is collecting PK data on children prescribed understudied drugs of interest per standard of care. (Drug)

结局指标

主要结局

Clearance (CL) or apparent oral clearance (CL/F) as measured by PK sampling

时间窗: Data will be collected up to 180 days from the time of consent

Half-life (t1/2) as measured by PK sampling

时间窗: Data will be collected up to 180 days from the time of consent

Volume of distribution (V) or apparent oral volume of distribution (V/F) as measured by PK sampling

时间窗: Data will be collected up to 180 days from the time of consent

AUC (area under the curve) as measured by PK sampling

时间窗: Data will be collected up to 180 days from the time of consent

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验